These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6752214)

  • 1. Enzyme studies in tardive dyskinesia. III. Noradrenergic hyperactivity in a subgroup of dyskinetic patients.
    Jeste DV; Linnoila M; Fordis CM; Phelps BH; Wagner RL; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):318-20. PubMed ID: 6752214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme studies in tardive dyskinesia. II. Familial aspects.
    Delisi LE; Jeste DV; Phelps BH; Wyatt RJ
    J Clin Psychopharmacol; 1982 Oct; 2(5):315-7. PubMed ID: 7130433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.
    Markianos M; Tripodianakis J; Garelis E
    Biol Psychiatry; 1983 Mar; 18(3):347-54. PubMed ID: 6132626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme studies in tardive dyskinesia. I. One-year biochemical follow-up.
    Wagner RL; Jeste DV; Phelps BH; Wyatt RD
    J Clin Psychopharmacol; 1982 Oct; 2(5):312-4. PubMed ID: 7130432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine trial in tardive dyskinesia. Therapeutic response, MHPG, and plasma DBH.
    Tripodianakis J; Markianos M
    Pharmacopsychiatry; 1986 Sep; 19(5):365-7. PubMed ID: 3534900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic and neuroradiological abnormalities in tardive dyskinesia.
    Kaufmann CA; Jeste DV; Shelton RC; Linnoila M; Kafka MS; Wyatt RJ
    Biol Psychiatry; 1986 Jul; 21(8-9):799-812. PubMed ID: 3015270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inheritance of low immunoreactive human plasma dopamine-beta-hydroxylase. Radioimmunoassay studies.
    Dunnette J; Weinshilboum R
    J Clin Invest; 1977 Nov; 60(5):1080-7. PubMed ID: 908751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine beta hydroxylase (DBH) plasma activity in childhood mental disorders.
    Paclt I; Koudelová J; Pacltova D; Kopeckova M
    Neuro Endocrinol Lett; 2009; 30(5):604-9. PubMed ID: 20035263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma dopamine-beta-hydroxylase in depressed patients.
    Matuzas W; Meltzer HY; Uhlenhuth EH; Glass RM; Tong C
    Biol Psychiatry; 1982 Dec; 17(12):1415-24. PubMed ID: 7159639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in plasma dopamine-beta-hydroxylase and catecholamine concentrations during surgical removal of pheochromocytoma.
    Wocial B; Januszewicz W; Siedlecki I; Feltynowski T; Debiński W
    Endokrinologie; 1982 Feb; 79(1):131-9. PubMed ID: 7084126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and low plasma activity of dopamine-beta-hydroxylase in ADHD children.
    Kopecková M; Paclt I; Goetz P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):748-54. PubMed ID: 17187001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-beta-hydroxylase. An index of adrenergic function in hypertensive patients.
    Stone RA
    West J Med; 1975 Aug; 123(2):108-114. PubMed ID: 1179715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum dopamine beta hydroxylase activity and tardive dyskinesia.
    Glazer WM; Morgenstern H; Jeste DV; Zahner G; Hafez HM; Benarroche CL
    Psychoneuroendocrinology; 1987; 12(4):289-94. PubMed ID: 2889236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia.
    Miodownik C; Meoded A; Libov I; Bersudsky Y; Sela BA; Lerner V
    Clin Neuropharmacol; 2008; 31(4):197-203. PubMed ID: 18670243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High plasma clozapine levels in tardive dyskinesia.
    Pollack S; Lieberman J; Kleiner D; Szymanski S; Kane J; Borenstein M; Cooper T
    Psychopharmacol Bull; 1993; 29(2):257-62. PubMed ID: 8290674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A biochemical study of tardive dyskinesia in young male patients.
    Jeste DV; DeLisi LE; Zalcman S; Wise CD; Phelps BH; Rosenblatt JE; Potkin SG; Bridge TP; Wyatt RJ
    Psychiatry Res; 1981 Jun; 4(3):327-31. PubMed ID: 6115438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pro- and antioxidant processes in schizophrenics with tardive dyskinesia].
    Gałecki P; Pietras T; Florkowki A
    Psychiatr Pol; 2005; 39(6):1131-41. PubMed ID: 16526180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic function in schizophrenia.
    Glazer WM; Charney DS; Heninger GR
    Arch Gen Psychiatry; 1987 Oct; 44(10):898-904. PubMed ID: 3662745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivariate analysis of monoamine indices in patients with chronic schizophrenia.
    Frecska E; Bagdy G; Perenyi A; Arato M; Degrell I; Mogyorosy Z
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):291-5. PubMed ID: 2577713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.